More>Health>Recovery

Heart Failure Diagnosis: Three Key Indicators

Heart failure is a significant health condition that affects millions of people worldwide. Early detection and accurate diagnosis are crucial for effective management and improved patient outcomes. While heart failure can present with a variety of symptoms, medical professionals rely on three primary indicators to assess cardiac function and determine the likelihood of heart failure.

1. Echocardiogram-Derived Ejection Fraction (EF)

One of the most important diagnostic tools in evaluating heart function is the echocardiogram, which measures the ejection fraction. EF represents the percentage of blood pumped out of the heart's left ventricle with each beat. A normal EF typically measures above 50%. When EF falls below 50%, it indicates reduced cardiac efficiency and potential heart failure. This measurement helps classify heart failure into categories such as heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF).

2. Six-Minute Walk Test (6MWT)

Functional capacity is another critical aspect of heart failure assessment. The six-minute walk test serves as a practical evaluation of a patient's exercise tolerance. During this test, patients walk as far as possible in six minutes while being monitored for symptoms and oxygen levels. Generally, completing more than 550 meters suggests normal heart function, while shorter distances may indicate impaired cardiac performance. This test not only helps in diagnosis but also assists in determining the severity of the condition and guiding treatment plans.

3. Blood Biomarker: NT-proBNP Levels

Blood tests play a vital role in confirming heart failure diagnoses. One key biomarker used is N-terminal pro b-type natriuretic peptide (NT-proBNP). Elevated levels of this protein are strongly associated with cardiac stress and heart failure. The threshold values vary by age group when creatinine levels are normal: individuals under 50 years old with levels exceeding 450 pg/mL, those between 50 and 75 years with levels above 900 pg/mL, and patients over 75 years showing values greater than 1800 pg/mL are considered at high risk for heart failure. These biomarkers help clinicians differentiate heart failure from other conditions with similar symptoms.

Combining these three diagnostic indicators—ejection fraction, six-minute walk distance, and NT-proBNP levels—allows healthcare providers to make informed decisions regarding heart failure diagnosis and treatment. Each test provides unique insights into different aspects of cardiac function and patient well-being. Regular monitoring of these parameters can also help track disease progression and response to therapy, ultimately improving long-term health outcomes for patients living with heart failure.

AutumnNap2025-08-03 11:12:09
Comments (0)
Login is required before commenting.